We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
-3.74%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$309B
AUM Growth
-$29.4B
Cap. Flow
-$6.3B
Cap. Flow %
-2.04%
Top 10 Hldgs %
22.53%
Holding
3,477
New
138
Increased
1,588
Reduced
1,481
Closed
89

Top Sells

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$712M
2
META icon
Meta Platforms (Facebook)
META
+$565M
3
PYPL icon
PayPal
PYPL
+$556M
4
MS icon
Morgan Stanley
MS
+$541M
5
PFE icon
Pfizer
PFE
+$388M

Sector Composition

Rank Sector Weight
1 Technology 24.81%
2 Financials 12.45%
3 Healthcare 12.44%
4 Consumer Discretionary 11.85%
5 Industrials 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
REPX icon
2726
Riley Exploration Permian
REPX
$758M
$1.18M ﹤0.01%
+44,249
New +$1.19M
BSRR icon
2727
Sierra Bancorp
BSRR
$525M
$1.17M ﹤0.01%
45,568
+515
+1% +$13.7K
KB icon
2728
KB Financial Group
KB
$43.5B
$1.17M ﹤0.01%
+23,944
New +$1.18M
GNTY
2729
DELISTED
Guaranty Bancshares
GNTY
$1.17M ﹤0.01%
32,540
+179
+0.6% +$6.5K
OUST icon
2730
Ouster
OUST
$2.92B
$1.17M ﹤0.01%
31,251
+3,666
+13% +$135K
KRTX
2731
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$1.16M ﹤0.01%
65,457
-536
-0.8% -$60.3K
FNLC icon
2732
First Bancorp
FNLC
$399M
$1.16M ﹤0.01%
38,612
+378
+1% +$11.8K
FBRX icon
2733
Forte Biosciences
FBRX
$1.57B
$1.15M ﹤0.01%
1,614
LIND icon
2734
Lindblad Expeditions
LIND
$2.22B
$1.15M ﹤0.01%
84,007
+1,125
+1% +$18.1K
INDT
2735
DELISTED
INDUS Realty Trust, Inc. (MD) Common Stock
INDT
$1.15M ﹤0.01%
15,439
+209
+1% +$16K
IRMD icon
2736
iRadimed
IRMD
$1.18B
$1.15M ﹤0.01%
23,019
+3,666
+19% +$170K
EWTX icon
2737
Edgewise Therapeutics
EWTX
$4.73B
$1.15M ﹤0.01%
110,115
+16,765
+18% +$216K
FMTX
2738
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$1.15M ﹤0.01%
122,744
+1,291
+1% +$13.7K
OMER icon
2739
Omeros
OMER
$959M
$1.14M ﹤0.01%
188,343
+2,227
+1% +$13.9K
VERA icon
2740
Vera Therapeutics
VERA
$2.36B
$1.14M ﹤0.01%
53,623
+38,525
+255% +$829K
NAT icon
2741
Nordic American Tanker
NAT
$1.37B
$1.14M ﹤0.01%
612,899
+57,456
+10% +$102K
BWB icon
2742
Bridgewater Bancshares
BWB
$603M
$1.14M ﹤0.01%
65,782
+773
+1% +$13.5K
ALDX icon
2743
Aldeyra Therapeutics
ALDX
$93.5M
$1.14M ﹤0.01%
237,359
+662
+0.3% +$2.64K
PARAA
2744
DELISTED
Paramount Global Class A
PARAA
$1.13M ﹤0.01%
28,883
+7,999
+38% +$299K
PKE icon
2745
Park Aerospace
PKE
$819M
$1.13M ﹤0.01%
81,484
+767
+1% +$10.3K
AQB icon
2746
AquaBounty Technologies
AQB
$6.02M
$1.13M ﹤0.01%
26,344
+18,212
+224% +$633K
CVGI icon
2747
Commercial Vehicle Group
CVGI
$147M
$1.13M ﹤0.01%
133,884
+1,208
+0.9% +$9.78K
CIVB icon
2748
Civista Bancshares
CIVB
$589M
$1.13M ﹤0.01%
46,429
+529
+1% +$12.9K
VUZI icon
2749
Vuzix
VUZI
$224M
$1.12M ﹤0.01%
168,937
-15,613
-8% -$103K
AXTI icon
2750
AXT Inc
AXTI
$5.8B
$1.12M ﹤0.01%
156,946
-1,946
-1% -$14.6K

Similar funds

Nuveen's Q1 2022 Portfolio in Review

As of Q1 2022, Nuveen held 3,477 positions worth $309B, down 8.7% from $338B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q1 2022 filing shows 138 new, 1,588 increased, 1,481 reduced and 89 closed positions. Its largest new stake was Constellation Energy: 1,208,173 shares worth $59.5M. The largest sale was Qualcomm, an estimated $712M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.

  • Nuveen's largest Q1 2022 buy was Constellation Energy: 1,208,173 shares worth $59.5M.
  • Nuveen added most to Advanced Micro Devices in Q1 2022, an estimated $949M increase.
  • Nuveen's biggest Q1 2022 reduction was Qualcomm, cutting an estimated $712M.
  • Nuveen fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $264M.
  • Nuveen's ten largest holdings make up 23% of its $309B portfolio in Q1 2022.
  • Nuveen opened 138 new positions and closed 89 in Q1 2022.
  • Nuveen's portfolio value fell 8.7% quarter-over-quarter to $309B.

Based on Nuveen's 13F filing for Q1 2022, filed 16 May 2022.